BioCentury
ARTICLE | Clinical News

AMR101 regulatory update

February 20, 2012 8:00 AM UTC

Amarin said FDA informed the company that the agency will not schedule an advisory committee meeting to discuss an NDA for AMR101 to treat hypertriglyceridemia in patients with triglyceride levels >=5...